MedPath

An EEG study of chronic post stroke aphasia patients

Not Applicable
Conditions
Nervous System Diseases
Registration Number
PACTR202310887998176
Lead Sponsor
Fatma Fatahallah Kenawy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

1.Age over 18 years.
2.Patients presenting with first ever ischemic stroke causing aphasia (mixed expressive and receptive).
3.A duration of 3 months to 1 year from onset of stroke.
4.Mild to moderate aphasia according to Western aphasia battery scale (score >50).

Exclusion Criteria

1.Previous ischemic stroke or hemorrhagic stroke.
2.Contraindications to tDCS as: a history of epilepsy, intracranial surgeries, skull defects or pregnant females.
3. Scoring 14 or more out of 30 in Stroke Aphasia Depression Questionnaire 10.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.tDCS can be used to treat chronic post stroke aphasia and causes changes in resting state EEG.
Secondary Outcome Measures
NameTimeMethod
2.Explore the potential correlations between baseline resting state EEG in aphasic patients and structural brain lesions observed in MRI scans and baseline clinical skills.
© Copyright 2025. All Rights Reserved by MedPath